As of January 18, 2023, Portugal had the highest COVID-19 vaccination rate in Europe having administered 272.78 doses per 100 people in the country, while Malta had administered 258.49 doses per 100. The UK was the first country in Europe to approve the Pfizer/BioNTech vaccine for widespread use and began inoculations on December 8, 2020, and so far have administered 224.04 doses per 100. At the latest data, Belgium had carried out 253.89 doses of vaccines per 100 population. Russia became the first country in the world to authorize a vaccine - named Sputnik V - for use in the fight against COVID-19 in August 2020. As of August 4, 2022, Russia had administered 127.3 doses per 100 people in the country.
The seven-day rate of cases across Europe shows an ongoing perspective of which countries are worst affected by the virus relative to their population. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.
By August 2024, Cuba had administered the largest number of vaccines against COVID-19 per 100 inhabitants in the Latin American region, followed by Chile and Peru. According to recent estimates, the Caribbean country applied around 410 doses per 100 population, accounting for one of the largest vaccination rates observed not only in the Latin American region, but worldwide. In comparison, Haiti registered the lowest vaccination rate within the region, with only 5.87 doses administered per 100 inhabitants. Booster shots started To reinforce the immune protection against the fast spread of the SARS-CoV-2, governments began to introduce booster shots in their immunization programs aiming at strengthening people’s immune response against new contagious COVID-19 variants. In Latin America, Cuba was leading on booster shots relative to its population among a selection of countries, with around 88 percent of the population receiving the extra dose. In comparison, these numbers are higher than those for the European Union and the United States. Pharmaceutical research continues As Omicron becomes more prominent worldwide, and recombinant variants emerge, research efforts to prevent and control the disease continue to progress. As of June 2022, there were around 2,700 clinical trials to treat COVID-19 and 1,752 COVID-19 vaccines trials in clinical development. Other studies were focused on mild, moderate and severe COVID-19, complication support, and post-COVID symptoms, among others.For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
NOTE: This dataset replaces a previous one. Please see below. Chicago residents who are up to date with COVID-19 vaccines by ZIP Code, based on the reported home address and age group of the person vaccinated, as provided by the medical provider in the Illinois Comprehensive Automated Immunization Registry Exchange (I-CARE). “Up to date” refers to individuals who meet the CDC’s updated COVID-19 vaccination criteria based on their age and prior vaccination history. For surveillance purposes, up to date is defined based on the following criteria: People ages 5 years and older: · Are up to date when they receive 1+ doses of a COVID-19 vaccine during the current season. Children ages 6 months to 4 years: · Children who have received at least two prior COVID-19 vaccine doses are up to date when they receive one additional dose of COVID-19 vaccine during the current season, regardless of vaccine product. · Children who have received only one prior COVID-19 vaccine dose are up to date when they receive one additional dose of the current season's Moderna COVID-19 vaccine or two additional doses of the current season's Pfizer-BioNTech COVID-19 vaccine. · Children who have never received a COVID-19 vaccination are up to date when they receive either two doses of the current season's Moderna vaccine or three doses of the current season's Pfizer-BioNTech vaccine. This dataset takes the place of a previous dataset, which covers doses administered from December 15, 2020 through September 13, 2023 and is marked as historical: - https://data.cityofchicago.org/Health-Human-Services/COVID-19-Vaccinations-by-ZIP-Code/553k-3xzc. Data Notes: Weekly cumulative totals of people up to date are shown for each combination ZIP Code and age group. Note there are rows where age group is "All ages" so care should be taken when summing rows. Coverage percentages are calculated based on the cumulative number of people in each ZIP Code and age group who are considered up to date as of the week ending date divided by the estimated number of people in that subgroup. Population counts are obtained from the 2020 U.S. Decennial Census. For ZIP Codes mostly outside Chicago, coverage percentages are not calculated reliable Chicago-only population counts are not available. Actual counts may exceed population estimates and lead to coverage estimates that are greater than 100%, especially in smaller ZIP Codes with smaller populations. Additionally, the medical provider may report a work address or incorrect home address for the person receiving the vaccination, which may lead to over- or underestimation of vaccination coverage by geography. All coverage percentages are capped at 99%. Weekly cumulative counts and coverage percentages are reported from the week ending Saturday, September 16, 2023 onward through the Saturday prior to the dataset being updated. All data are provisional and subject to change. Information is updated as additional details are received and it is, in fact, very common for recent dates to be incomplete and to be updated as time goes on. At any given time, this dataset reflects data currently known to CDPH. Numbers in this dataset may differ from other public sources due to when data are reported and how City of Chicago boundaries are defined. The Chicago Department of Public Health uses the most complete data available to estimate COVID-19 vaccination coverage among Chicagoans, but there are several limitations that impact our estimates. Individuals may receive vaccinations that are not recorded in the Illinois immunization registry, I-CARE, such as those administered in another state, causing underestimation of the number individuals who are up to date. Inconsistencies in records of separate doses administered to the same person, such as slight variations in dates of birth, can result in duplicate records for a person and underestimate the number of people who are up to date. For all datasets related to COVID-19, please
The annual pre-kindergarten (pre-K) through 12th grade school immunization survey collects school-level, grade-specific data on vaccine coverage and exemptions. The survey collects vaccination and exemption status data on children who entered the school system on or before a specified date during the fall semester. Individual vaccine information on each student is not collected. This table shows the percentage of kindergarten students vaccinated for each school-entry mandated vaccine series and the percentage with vaccination exemptions (medical or religious) reported by school. Percentage of students vaccinated is the number of students with the required number of doses of a given vaccine divided by the total number of students. Data includes all schools who reported students in kindergarten. School-mandated vaccine series for students enrolled in kindergarten are inactivated polio, DTaP (diphtheria, tetanus, and acellular pertussis), MMR (measles, mumps, and rubella), hepatitis B, varicella, and hepatitis A. Each child has 1 of 4 possible vaccination statuses: Vaccinated, Exempt (Religious), Exempt (Medical) or Not Complete. The criteria shown below are used to assess whether a child is considered vaccinated. • Polio = at least 3 doses of inactivated polio vaccine, with the last dose on or after their 4th birthday. This is a school entry requirement starting in kindergarten. • DTaP = at least 4 doses of DTaP vaccine, with the last dose on or after their 4th birthday. This is a school entry requirement starting in kindergarten. • MMR = at least 2 doses of MMR vaccine separated by at least 28 days, with the 1st dose on or after their 1st birthday. This is a school entry requirement starting in kindergarten. • HepB = at least 3 doses of hepatitis B vaccine, with the last dose on or after 24 weeks of age. This is a school entry requirement starting in kindergarten. • Varicella = at least 2 doses of varicella vaccine separated by at least 28 days, with the 1st dose on or after their 1st birthday, or a reliable history of chickenpox disease. This is a school entry requirement starting in kindergarten. • HepA = at least 2 doses of hepatitis A vaccine, given a minimum of six calendar months apart, with the 1st dose on or after their 1st birthday. This is a school entry requirement starting in kindergarten. • All = Percentage of students with all above vaccine series required for that grade level. Children without a record of vaccination, but with serologic proof of immunity to certain diseases (measles, mumps, rubella, hepatitis B, hepatitis A, and varicella), meet school entry requirements and may be counted as vaccinated. The values for schools with fewer than 30 enrolled kindergarteners are suppressed, and those fields are left blank. Data Limitations and Considerations: • The school level data shown here are as tabulated and reported by schools and discrepancies may exist. • The Immunization Program identifies outliers and internally inconsistent data points and works with schools to resolve any data quality issues, when possible. • CT DPH cannot verify the accuracy of vaccine data for individual children or whether the documentation necessary to claim an exemption has been submitted. • Data are collected at the beginning of the school year, by which time vaccines are due. As the year progresses, immunization rates may increase as additional children receive required immunizations. Additionally, the student body is dynamic and as students arrive and leave school, the immunization rates are impacted. • Vaccine status is assessed on the level of the child and not on each vaccine. Once a child is listed as exempt, vaccination data is no longer collected in the survey for that child. Therefore, children with exemptions are not counted as vaccinated in the vaccine level assessments although they may have received some vaccines. • One school was excluded due to a data collection error.
Note: In these datasets, a person is defined as up to date if they have received at least one dose of an updated COVID-19 vaccine. The Centers for Disease Control and Prevention (CDC) recommends that certain groups, including adults ages 65 years and older, receive additional doses.
On 6/16/2023 CDPH replaced the booster measures with a new “Up to Date” measure based on CDC’s new recommendations, replacing the primary series, boosted, and bivalent booster metrics The definition of “primary series complete” has not changed and is based on previous recommendations that CDC has since simplified. A person cannot complete their primary series with a single dose of an updated vaccine. Whereas the booster measures were calculated using the eligible population as the denominator, the new up to date measure uses the total estimated population. Please note that the rates for some groups may change since the up to date measure is calculated differently than the previous booster and bivalent measures.
This data is from the same source as the Vaccine Progress Dashboard at https://covid19.ca.gov/vaccination-progress-data/ which summarizes vaccination data at the county level by county of residence. Where county of residence was not reported in a vaccination record, the county of provider that vaccinated the resident is included. This applies to less than 1% of vaccination records. The sum of county-level vaccinations does not equal statewide total vaccinations due to out-of-state residents vaccinated in California.
These data do not include doses administered by the following federal agencies who received vaccine allocated directly from CDC: Indian Health Service, Veterans Health Administration, Department of Defense, and the Federal Bureau of Prisons.
Totals for the Vaccine Progress Dashboard and this dataset may not match, as the Dashboard totals doses by Report Date and this dataset totals doses by Administration Date. Dose numbers may also change for a particular Administration Date as data is updated.
Previous updates:
On March 3, 2023, with the release of HPI 3.0 in 2022, the previous equity scores have been updated to reflect more recent community survey information. This change represents an improvement to the way CDPH monitors health equity by using the latest and most accurate community data available. The HPI uses a collection of data sources and indicators to calculate a measure of community conditions ranging from the most to the least healthy based on economic, housing, and environmental measures.
Starting on July 13, 2022, the denominator for calculating vaccine coverage has been changed from age 5+ to all ages to reflect new vaccine eligibility criteria. Previously the denominator was changed from age 16+ to age 12+ on May 18, 2021, then changed from age 12+ to age 5+ on November 10, 2021, to reflect previous changes in vaccine eligibility criteria. The previous datasets based on age 16+ and age 5+ denominators have been uploaded as archived tables.
Starting on May 29, 2021 the methodology for calculating on-hand inventory in the shipped/delivered/on-hand dataset has changed. Please see the accompanying data dictionary for details. In addition, this dataset is now down to the ZIP code level.
https://www.usa.gov/government-workshttps://www.usa.gov/government-works
Overall US COVID-19 Vaccine administration and vaccine equity data at county level. Data represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Note: 11/1/2023: Publication of the COVID data will be delayed because of technical difficulties. Note: 9/20/2023: With the end of the federal emergency and reporting requirements continuing to evolve, the Indiana Department of Health will no longer publish and refresh the COVID-19 datasets after November 15, 2023 - one final dataset publication will continue to be available. Vaccination demographics data by county/region, by race, by ethnicity, by gender, and by age. Fields with less than 5 results have been marked as suppressed. Note: 3/22/2023: Due to a technical issue updates are delayed for COVID data. New files will be published as soon as they are available. Historical Changes: 1/5/2023: Due to a technical issue the COVID datasets were not updated on 1/4/23. Updates will be published as soon as they are available. 9/29/22: Due to a technical difficulty, the weekly COVID datasets were not generated yesterday. They will be updated with current data today - 9/29 - and may result in a temporary discrepancy with the numbers published on the dashboard until the normal weekly refresh resumes 10/5. 9/27/2022: As of 9/28, the Indiana Department of Health (IDOH) is moving to a weekly COVID update for the dashboard and all associated datasets to continue to provide trend data that is applicable and usable for our partners and the public. This is to maintain alignment across the nation as states move to weekly updates. 8/19/2022 - The first and second dose columns are being removed as of 8/22/22 as the Health department has transitioned to reporting on Fully/Partially vaccinated. The final historical file including these columns from 8/19 will continue to be available. 2/10/2022: Data was not published on 2/9/2022 due to a technical issue, but updated data was released 2/10/2022. 10/13/2021: This dataset now includes columns for new and total booster shots administered. Please see the data dictionary for additional details. 08/06/2021: There are updates today to county-level vaccination rates to reflect a correction to records that were assigned to the wrong location based on ZIP code. 06/23/2021: COVID Hub files will no longer be updated on Saturdays. The normal refresh of these files has been changed to Mon-Fri. 06/10/2021: COVID Hub files will no longer be updated on Sundays. The normal refresh of these files has been changed to Mon-Sat. 06/07/2021: Today’s new counts include doses newly reported to the Indiana Department of Health on Saturday and Sunday. 06/03/2021: Individuals are able to update their personal and demographic information during the vaccination registration process. Today’s data reflects changes made by individuals to their race, ethnicity, or county of residence over the course of their vaccination series. 05/13/2021: The 12-15 year-old age group has been added into the dataset as of today. 05/06/2021: On Monday 5/3, individuals classified as "Unknown" county of residence were inadvertently converted to "Out of State." These individuals have been corrected in today's dataset. 03/11/2021: This dataset has been updated to include totals and newly administered single dose vaccination data. Additionally the existing age groups have been further stratified into a 16-19 year old age group, and 5 year groups for 20-79 year olds.
Vaccination rates among one-year-olds have risen drastically in the past four decades, with global coverage for some of the most important vaccines increasing from below twenty percent in 1980 to above eighty percent in 2021. Several vaccines introduced on a larger scale in the 1990s, such as the Hepatitis B vaccine, have increased from just one percent coverage to well over two thirds coverage today. As many infants receive multiple vaccines at one time, or as barriers to healthcare access are lifted, this has meant that global coverage trends have been fairly similar for the most common vaccines, and that coverage for newly developed vaccines has grown relatively quickly (such as the Hepatitis B and Inactivated Polio vaccines). Recent backsliding The COVID-19 pandemic marked the first time in recent history where coverage among one year olds dropped for multiple vaccines. In some cases, global coverage fell by as much as five or six percent for vaccines including diptheria/pertussus/tetanus, hepatitus B, measles, and polio. This backslide has been attributed to a variety of factors, such as weakened healthcare systems in less developed regions, the spread of misinformation surrounding vaccines, disruptions due to containment measures, supply chain issues, and the diversion of medical resources. It had been hoped that 2020 would be an anomaly, and that figures would return to their previous trajectory in 2021, but rising malnutrition and and weaker food supply to the poorest regions has exacerbated this further.
NOTE: This dataset has been retired and marked as historical-only. The recommended dataset to use in its place is https://data.cityofchicago.org/Health-Human-Services/COVID-19-Vaccination-Coverage-Citywide/6859-spec. COVID-19 vaccinations administered to Chicago residents based on the reported race-ethnicity and age group of the person vaccinated, as provided by the medical provider in the Illinois Comprehensive Automated Immunization Registry Exchange (I-CARE). Vaccination Status Definitions: ·People with at least one vaccine dose: Number of people who have received at least one dose of any COVID-19 vaccine, including the single-dose Johnson & Johnson COVID-19 vaccine. ·People with a completed vaccine series: Number of people who have completed a primary COVID-19 vaccine series. Requirements vary depending on age and type of primary vaccine series received. ··People with an original booster dose: Number of people who have a completed vaccine series and have received at least one additional monovalent dose. This includes people who received a monovalent booster dose and immunocompromised people who received an additional primary dose of COVID-19 vaccine. Monovalent doses were created from the original strain of the virus that causes COVID-19. People with a bivalent dose: Number of people who received a bivalent (updated) dose of vaccine. Updated, bivalent doses became available in Fall 2022 and were created with the original strain of COVID-19 and newer Omicron variant strains. Weekly cumulative totals by vaccination status are shown for each combination of race-ethnicity and age group. Note that each age group has a row where race-ethnicity is "All" so care should be taken when summing rows. Vaccinations are counted based on the date on which they were administered. Weekly cumulative totals are reported from the week ending Saturday, December 19, 2020 onward (after December 15, when vaccines were first administered in Chicago) through the Saturday prior to the dataset being updated. Population counts are from the U.S. Census Bureau American Community Survey (ACS) 2019 1-year estimates. For some of the age groups by which COVID-19 vaccine has been authorized in the United States, race-ethnicity distributions were specifically reported in the ACS estimates. For others, race-ethnicity distributions were estimated by the Chicago Department of Public Health (CDPH) by weighting the available race-ethnicity distributions, using proportions of constituent age groups. Coverage percentages are calculated based on the cumulative number of people in each population subgroup (age group by race-ethnicity) who have each vaccination status as of the date, divided by the estimated number of Chicago residents in each subgroup. Actual counts may exceed population estimates and lead to >100% coverage, especially in small race-ethnicity subgroups of each age group. All coverage percentages are capped at 99%. All data are provisional and subject to change. Information is updated as additional details are received and it is, in fact, very common for recent dates to be incomplete and to be updated as time goes on. At any given time, this dataset reflects data currently known to CDPH. Numbers in this dataset may differ from other public sources due to when data are reported and how City of Chicago boundaries are defined. CDPH uses the most complete data available to estimate COVID-19 vaccination coverage among Chicagoans, but there are several limitations that impact our estimates. Data reported in I-CARE only include doses administered in Illinois and some doses administered outside of Illinois reported historically by Illinois providers. Doses administered by the federal Bureau of Prisons and Department of Defense are also not currently reported in I-CARE. The Veterans Health Administration began reporting doses in I-CARE beginning September 2022. Due to people receiving vaccinations that are not recorded in I-CARE that c
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
NOTE: As of 2/16/2023, this table is not being updated. For data on COVID-19 updated (bivalent) booster coverage by town please to go to https://data.ct.gov/Health-and-Human-Services/COVID-19-Updated-Bivalent-Booster-Coverage-By-Town/bqd5-4jgh.
This table shows the number and percent of residents of each CT town that have initiated COVID-19 vaccination, are fully vaccinated and who have received additional dose 1.
All data in this report are preliminary; data for previous dates will be updated as new reports are received and data errors are corrected.
In the data shown here, a person who has received at least one dose of COVID-19 vaccine is considered to have initiated vaccination. A person is considered fully vaccinated if he/she has completed a primary vaccination series by receiving 2 doses of the Pfizer, Novavax or Moderna vaccines or 1 dose of the Johnson & Johnson vaccine. The fully vaccinated are a subset of the people who have received at least one dose.
A person who completed a Pfizer, Moderna, Novavax or Johnson & Johnson primary series (as defined above) and then had an additional monovalent dose of COVID-19 vaccine is considered to have had additional dose 1. The additional dose may be Pfizer, Moderna, Novavax or Johnson & Johnson and may be a different type from the primary series. For people who had a primary Pfizer or Moderna series, additional dose 1 was counted starting August 18th, 2021. For people with a Johnson & Johnson primary series additional dose 1 was counted starting October 22nd, 2021. For most people, additional dose 1 is a booster. However, additional dose 1 may represent a supplement to the primary series for a people who is moderately or severely immunosuppressed. Bivalent booster administrations are not included in the additional dose 1 calculations.
The percent with at least one dose many be over-estimated, and the percent fully vaccinated and with additional dose 1 may be under-estimated because of vaccine administration records for individuals that cannot be linked because of differences in how names or date of birth are reported.
Percentages are calculated using 2019 census data (https://portal.ct.gov/DPH/Health-Information-Systems--Reporting/Population/Annual-Town-and-County-Population-for-Connecticut).
Town of residence is verified by geocoding the reported address and then mapping it to a town using municipal boundaries. If an address cannot be geocoded, the reported town is used, if available. People for whom an address is not currently available are shown in this table as “Address pending validation”. Out-of-state residents vaccinated by CT providers are excluded from the table.
Town-level coverage estimates have been capped at 100%. Observed coverage may be greater than 100% for multiple reasons, including census denominator data not including all individuals that currently reside in the town (e.g., part time residents, change in population size since the census), errors in address data or other reporting errors. Also, the percent with at least one dose many be over-estimated, and the percent fully vaccinated and with additional dose 1 may be under-estimated when records for an individual cannot be linked because of differences in how names or date of birth are reported.
Caution should be used when interpreting coverage estimates for towns with large college/university populations since coverage may be underestimated. In the census, college/university students who live on or just off campus would be counted in the college/university town. However, if a student was vaccinated while studying remotely in his/her hometown, the student may be counted as a vaccine recipient in that town.
SVI refers to the CDC's Social Vulnerability Index - a measure that combines 15 demographic variables to identify communities most vulnerable to negative health impacts from disasters and public health crises. Measures of social vulnerability include socioeconomic status, household composition, disability, race, ethnicity, language, and transportation limitations - among others. Towns with a "yes" in the "Has SVI tract >0.75" field are those that have at least one census tract that is in the top quartile of vulnerability (e.g., a high-need area). 34 towns in Connecticut have at least one census tract in the top quartile for vulnerability.
Connecticut COVID-19 Vaccine Program providers are required to report information on all COVID-19 vaccine doses administered to CT WiZ, the Connecticut Immunization Information System. Data on doses administered to CT residents out-of-state are being added to CT WiZ jurisdiction-by-jurisdiction. Doses administered by some Federal entities (including Department of Defense, Department of Correction, Department of Veteran’s Affairs, Indian Health Service) are not yet reported to CT WiZ. Data reported here reflect the vaccination records currently reported to CT WiZ.
Note: This dataset takes the place of the original "COVID-19 Vaccinations by Town" dataset (https://data.ct.gov/Health-and-Human-Services/COVID-19-Vaccinations-by-Town/pdqi-ds7f) , which will not be updated after 4/15/2021. A breakdown of vaccinations by town and by age group is also available here: https://data.ct.gov/Health-and-Human-Services/COVID-19-Vaccinations-by-Town-and-Age-Group/gngw-ukpw .
As part of continuous data quality improvement efforts, duplicate records were removed from the COVID-19 vaccination data during the weeks of 4/19/2021 and 4/26/2021.
NOTE: After 10/20/2021, this dataset will no longer be updated and will be replaced by the new dataset: "COVID-19 Vaccinations by Race/Ethnicity" (https://data.ct.gov/Health-and-Human-Services/COVID-19-Vaccinations-by-Race-Ethnicity/4z97-pa4q). Percentage of people who initiated COVID-19 vaccination by race/ethnicity as reported by providers. Population estimates are based on 2019 CT population estimates. The 2019 CT population data which is the most recent year available. In this data, a person with reported Hispanic or Latino ethnicity is considered Hispanic regardless of reported race. The category Unknown includes unknown race and/or ethnicity. A vaccine coverage percentage cannot be calculated for people classified as NH Other race given a lack of census data for this group. Data quality assurance activities suggest that NH Other may represent a missing value. The estimated vaccine coverage percentages shown here may be underestimated for race/ethnicity groups because of missing data. All data in this report are preliminary; data for previous dates will be updated as new reports are received and data errors are corrected.
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
NOTE: As of 2/16/2023, This page is not being updated, for data on COVID-19 Updated (Bivalent) Booster Coverage go to https://data.ct.gov/Health-and-Human-Services/COVID-19-Updated-Bivalent-Booster-Coverage-By-Town/bqd5-4jgh.
Important change as of June 1, 2022
As of June 1, 2022, we will be using 2020 DPH provisional census estimates* to calculate vaccine coverage percentages at the county level. 2020 estimates will replace the 2019 estimates that have been used. Caution should be taken when making comparisons of percentages calculated using the 2019 and 2020 census estimates since observed difference may result from the shift in the denominator.
This tables shows the number and percent of people that have initiated COVID-19 vaccination, are fully vaccinated and had additional dose 1 by county of residence.
All data in this report are preliminary; data for previous dates will be updated as new reports are received and data errors are corrected.
Population size estimates are based on 2019 DPH census estimates until 5/26/2022. From 6/1/2022, 2020 DPH provisional census estimates are used.
A person who has received at least one dose of any COVID-19 vaccine is considered to have initiated vaccination. A person is considered fully vaccinated if they have completed a primary series by receiving 2 doses of the Pfizer, Novavax or Moderna vaccines or 1 dose of the Johnson & Johnson vaccine. The fully vaccinated are a subset of the number who have initiated vaccination. Percentages are calculated using 2019 census data (https://portal.ct.gov/DPH/Health-Information-Systems--Reporting/Population/Annual-Town-and-County-Population-for-Connecticut).
A person who completed a Pfizer, Moderna, Novavax or Johnson & Johnson primary series (as defined above) and then had an additional monovalent dose of COVID-19 vaccine is considered to have had additional dose 1. The additional dose may be Pfizer, Moderna, Novavax or Johnson & Johnson and may be a different type from the primary series. For people who had a primary Pfizer or Moderna series, additional dose 1 was counted starting August 18th, 2021. For people with a Johnson & Johnson primary series additional dose 1 was counted starting October 22nd, 2021. For most people, additional dose 1 is a booster. However, additional dose 1 may represent a supplement to the primary series for a people who is moderately or severely immunosuppressed. Bivalent booster administrations are not included in the additional dose 1 calculations.
The percent with at least one dose may be over-estimated and the percent fully and additional dose 1 vaccinated may be under-estimated because of vaccine administration records for individuals that cannot be linked because of differences in how names or date of birth are reported.
County of residence is determined based on the town of residence. Town of residence is verified by geocoding the reported address and then mapping it to a town using municipal boundaries. If an address cannot be geocoded, the reported town is used, if available. Out-of-state residents vaccinated by CT providers excluded from this table. People for whom an address is not currently available are shown in this table as “Address pending validation”.
Connecticut COVID-19 Vaccine Program providers are required to report information on all COVID-19 vaccine doses administered to CT WiZ, the Connecticut Immunization Information System. Data on doses administered to CT residents out-of-state are being added to CT WiZ jurisdiction-by-jurisdiction. Doses administered by some Federal entities (including Department of Defense, Department of Correction, Department of Veteran’s Affairs, Indian Health Service) are not yet reported to CT WiZ. Data reported here reflect the vaccination records currently reported to CT WiZ. Note: As part of continuous data quality improvement efforts, duplicate records were removed from the COVID-19 vaccination data during the weeks of 4/19/2021 and 4/26/2021.
This is one of three datasets related to the Prevention Agenda Tracking Indicators county level data posted on this site. Each dataset consists of county level data for 68 health tracking indicators and sub-indicators for the Prevention Agenda 2013-2017: New York State’s Health Improvement Plan. A health tracking indicator is a metric through which progress on a certain area of health improvement can be assessed. The indicators are organized by the Priority Area of the Prevention Agenda as well as the Focus Area under each Priority Area. Each dataset includes tracking indicators for the five Priority Areas of the Prevention Agenda 2013-2017. The latest data dataset includes the most recent county level data for all indicators. The trend dataset includes the most recent county level data and historical data, where available. Each dataset also includes the Prevention Agenda 2017 state targets for the indicators. Sub-indicators are included in these datasets to measure health disparities among socioeconomic groups. For more information, check out: http://www.health.ny.gov/prevention/prevention_agenda/2013-2017/ and https://www.health.ny.gov/PreventionAgendaDashboard, or go to the “About” tab.
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
NOTE: As of 2/16/2023, this table is no longer being updated. For data on COVID-19 Updated (Bivalent) Booster Coverage by Age go to https://data.ct.gov/Health-and-Human-Services/COVID-19-Updated-Bivalent-Booster-Coverage-By-Age-/j2me-7k56. For information on COVID-19 vaccination primary series coverage for people less than 5 years go to https://data.ct.gov/Health-and-Human-Services/COVID-19-Vaccination-Primary-Series-Coverage-Age-L/su9q-qn6e
Important change as of June 1, 2022
As of June 1, 2022, we will be using 2020 DPH provisional census estimates* to calculate vaccine coverage percentages for state- and county-level tables (except coverage by CT SVI priority zip code). 2020 estimates will replace the 2019 estimates that have been used. Caution should be taken when making comparisons of percentages calculated using the 2019 and 2020 census estimates since observed difference may result from the shift in the denominator. The age groups in the state-level data tables will also be changing as a result of the switch to the new denominator.
This tables shows the number and percent of people that have initiated COVID-19 vaccination, are fully vaccinated, and addition dose 1 by age group. Age is based on age at the time of administration of the first dose.
All data in this report are preliminary; data for previous dates will be updated as new reports are received, and data errors are corrected.
Population size estimates are based on 2019 DPH census estimates until 5/26/2022. From 6/1/2022, 2020 DPH provisional census estimates are used.
In the data shown here, a person who has received at least one dose of COVID-19 vaccine is considered to have initiated vaccination. A person is considered fully vaccinated if he/she has completed a primary vaccination series by receiving 2 doses of the Pfizer, Novavax or Moderna vaccines or 1 dose of the Johnson & Johnson vaccine. The fully vaccinated are a subset of the people who have received at least one dose.
A person who completed a Pfizer, Moderna, Novavax or Johnson & Johnson primary series (as defined above) and then had an additional monovalent dose of COVID-19 vaccine is considered to have had additional dose 1. The additional dose may be Pfizer, Moderna, Novavax or Johnson & Johnson and may be a different type from the primary series. For people who had a primary Pfizer or Moderna series, additional dose 1 was counted starting August 18th, 2021. For people with a Johnson & Johnson primary series additional dose 1 was counted starting October 22nd, 2021. For most people, additional dose 1 is a booster. However, additional dose 1 may represent a supplement to the primary series for a people who is moderately or severely immunosuppressed. Bivalent booster administrations are not included in the additional dose 1 calculations.
The percent with at least one dose many be over-estimated, and the percent fully vaccinated and with additional dose 1 may be under-estimated because of vaccine administration records for individuals that cannot be linked because of differences in how names or date of birth are reported.
Town-level coverage estimates have been capped at 100%. Observed coverage may be greater than 100% for multiple reasons, including census denominator data not including all individuals that currently reside in the town (e.g., part time residents, change in population size since the census), errors in address data or other reporting errors. Also, the percent with at least one dose many be over-estimated, and the percent fully vaccinated and with additional dose 1 may be under-estimated when records for an individual cannot be linked because of differences in how names or date of birth are reported.
Connecticut COVID-19 Vaccine Program providers are required to report information on all COVID-19 vaccine doses administered to CT WiZ, the Connecticut Immunization Information System. This includes doses given to residents of CT and to residents of other states vaccinated in CT. Data on doses administered to CT residents out-of-state are being added to CT WiZ jurisdiction-by-jurisdiction. Doses administered by some Federal entities (including Department of Defense, Department of Correction, Department of Veteran’s Affairs, Indian Health Service) are not yet reported to CT WiZ. Data reported here reflect the vaccination records reported to CT WiZ. However, once CT residents who have received doses in each jurisdiction are added to CT WiZ, the records for residents of that jurisdiction vaccinated in CT are removed. For example, when CT residents vaccinated in NYC were added, NYC residents vaccinated in CT were removed.
Note: As part of continuous data quality improvement efforts, duplicate records were removed from the COVID-19 vaccination data during the weeks of 4/19/2021 and 4/26/2021.
As of March 20, 2023, around 391 doses of COVID-19 vaccines per 100 people in Cuba had been administered, one of the highest COVID-19 vaccine dose rates of any country worldwide. This statistic shows the rate of COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country or territory.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
This statistical report, co-authored with the UK Health Security Agency (UKSHA), reports childhood vaccination coverage statistics for England in 2021-22. Data relates to the routine vaccinations offered to all children up to the age of 5 years, derived from the Cover of Vaccination Evaluated Rapidly (COVER). Additional information on children aged 2 and 3 vaccinated against seasonal flu are collected from GPs through UKHSA's ImmForm system.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Vaccination rates and odds ratios by socio-demographic group among people living in England.
The annual pre-kindergarten (pre-K) through 12th grade school immunization survey collects school-level, grade-specific data on vaccine coverage and exemptions. The survey collects vaccination and exemption status data on children who entered the school system on or before a specified date during the fall semester. Individual vaccine information on each student is not collected. This table shows the vaccination exemptions (medical and religious) and percentage vaccinated and compliant for each school-entry mandated vaccine series reported by school year, county, and grade. Percentage of students vaccinated is the number of students with the required number of doses of a given vaccine divided by the total number of students. Data for each grade includes all schools who reported with that given grade level. School-mandated vaccine series for students enrolled in kindergarten are inactivated polio, DTaP (diphtheria, tetanus, and acellular pertussis), MMR (measles, mumps, and rubella), hepatitis B, varicella and hepatitis A. Additional mandated vaccines for students enrolled in 7th grade include meningococcal conjugate vaccine (MCV) and Tdap (tetanus, diphtheria, and acellular pertussis). Influenza vaccine is a requirement for pre-K students only, who are 24 through 59 months of age. Each child has 1 of 4 possible vaccination statutes: Vaccinated, Exempt (Religious), Exempt (Medical) or Non-compliant. The criteria shown below are used to assess whether a child is considered vaccinated. • Flu = at least 1 dose of annual influenza vaccine (pre-K only). This is a school entry requirement only for pre-K students 24 through 59 months of age. • Polio = at least 3 doses of inactivated polio vaccine, with the last dose on or after their 4th birthday. This is a school entry requirement starting in kindergarten. • DTaP = at least 4 doses of DTaP vaccine, with the last dose on or after their 4th birthday. This is a school entry requirement starting in kindergarten. • MMR = at least 2 doses of MMR vaccine separated by at least 28 days, with the 1st dose on or after their 1st birthday. This is a school entry requirement starting in kindergarten. • HepB = at least 3 doses of hepatitis B vaccine, with the last dose on or after 24 weeks of age. This is a school entry requirement starting in kindergarten. • Varicella = at least 2 doses of varicella vaccine separated by at least 28 days, with the 1st dose on or after their 1st birthday, or a reliable history of chickenpox disease. This is a school entry requirement starting in kindergarten. • HepA = at least 2 doses of hepatitis A vaccine, given a minimum of six calendar months apart, with the 1st dose on or after their 1st birthday. This is a school entry requirement starting in kindergarten. Starting with the 2019-2020 school year the annual survey included data collection on hepatitis A vaccine for 7th grade students. • MCV = at least 1 dose of meningococcal conjugate vaccine. This is a school entry requirement starting in 7th grade. • Tdap = at least 1 dose of Tdap vaccine. This is a school entry requirement starting in 7th grade. • All = Percentage of students with all above vaccine series required for that grade level. Children without a record of vaccination, but with serologic proof of immunity to certain diseases (measles, mumps, rubella, hepatitis B, hepatitis A, and varicella), meet school entry requirements and may be counted as vaccinated. Data Limitations and Considerations: • The school level data shown here are as tabulated and reported by schools and discrepancies may exist. • The Immunization Program identifies outliers and internally inconsistent data points and works with schools to resolve any data quality issues, when possible. • CT DPH cannot verify the accuracy of vaccine data for individual children or whether the documentation necessary to claim an exemption has been submitted. • Data are collected at the beginning of the school year, by which time vaccines are due.
U.S. Government Workshttps://www.usa.gov/government-works
License information was derived automatically
This table will no longer be updated after 5/30/2024 given the end of the 2023-2024 viral respiratory vaccine season.
This table shows the cumulative number and percentage of CT residents who have received an updated COVID-19 vaccine during the 2023-2024 viral respiratory season by age group (current age).
CDC recommends that people get at least one dose of this vaccine to protect against serious illness, whether or not they have had a COVID-19 vaccination before. Children and people with moderate to severe immunosuppression might be recommended more than one dose. For more information on COVID-19 vaccination recommendations, click here.
• Data are reported weekly on Thursday and include doses administered to Saturday of the previous week (Sunday – Saturday). All data in this report are preliminary. Data from the previous week may be changed because of delays in reporting, deduplication, or correction of errors.
• These analyses are based on data reported to CT WiZ which is the immunization information system for CT. CT providers are required by law to report all doses of vaccine administered. CT WiZ also receives records on CT residents vaccinated in other jurisdictions and by federal entities which share data with CT Wiz electronically. Electronic data exchange is being added jurisdiction-by-jurisdiction. Currently, this includes Rhode Island and New York City but not Massachusetts and New York State. Therefore, doses administered to CT residents in neighboring towns in Massachusetts and New York State will not be included. A full list of the jurisdiction with which CT has established electronic data exchange can be seen at the bottom of this page (https://portal.ct.gov/immunization/Knowledge-Base/Articles/Vaccine-Providers/CT-WiZ-for-Vaccine-Providers-and-Training/Query-and-Response-functionality-in-CT-WiZ?language=en_US)
• Population size estimates used to calculate cumulative percentages are based on 2020 DPH provisional census estimates*.
• People are included if they have an active jurisdictional status in CT WiZ at the time weekly data are pulled. This excludes people who live out of state, are deceased and a small percentage who have opted out of CT WiZ.
* DPH Provisional State and County Characteristics Estimates April 1, 2020. Hayes L, Abdellatif E, Jiang Y, Backus K (2022) Connecticut DPH Provisional April 1, 2020, State Population Estimates by 18 age groups, sex, and 6 combined race and ethnicity groups. Connecticut Department of Public Health, Health Statistics & Surveillance, SAR, Hartford, CT.
NOTE: As of 2/16/2023 this table is no longer being updated. For information on COVID-19 Updated (Bivalent) Booster Coverage, go to https://data.ct.gov/Health-and-Human-Services/COVID-19-Updated-Bivalent-Booster-Coverage-By-Race/8267-bg4w. Important change as of June 1, 2022 As of June 1, 2022, we will be using 2020 DPH provisional census estimates* to calculate vaccine coverage percentages by age at the state level. 2020 estimates will replace the 2019 estimates that have been used. Caution should be taken when making comparisons of percentages calculated using the 2019 and 2020 census estimates since observed difference may result from the shift in the denominator. The age groups in the state-level data tables will also be changing as a result of the switch to the new denominator. DPH Provisional State and County Characteristics Estimates April 1, 2020. Hayes L, Abdellatif E, Jiang Y, Backus K (2022) Connecticut DPH Provisional April 1, 2020 State Population Estimates by 18 age groups, sex, and 6 combined race and ethnicity groups. Connecticut Department of Public Health, Health Statistics & Surveillance, SAR, Hartford, CT. This table shows the number and percent of people that have initiated COVID-19 vaccination, are fully vaccinated and had additional dose 1 by race / ethnicity and age group. All data in this report are preliminary; data for previous dates will be updated as new reports are received and data errors are corrected. The age groups in the state-level data tables will also be changing as a result of the switch to the new denominator. Population size estimates are based on 2019 DPH census estimates until 5/26/2022. From 6/1/2022, 2020 DPH provisional census estimates are used. In the data shown here, a person who has received at least one dose of COVID-19 vaccine is considered to have initiated vaccination. A person is considered fully vaccinated if he/she has completed a primary vaccination series by receiving 2 doses of the Pfizer, Novavax or Moderna vaccines or 1 dose of the Johnson & Johnson vaccine. The fully vaccinated are a subset of the people who have received at least one dose. A person who completed a Pfizer, Moderna, Novavax or Johnson & Johnson primary series (as defined above) and then had an additional monovalent dose of COVID-19 vaccine is considered to have had additional dose 1. The additional dose may be Pfizer, Moderna, Novavax or Johnson & Johnson and may be a different type from the primary series. For people who had a primary Pfizer or Moderna series, additional dose 1 was counted starting August 18th, 2021. For people with a Johnson & Johnson primary series additional dose 1 was counted starting October 22nd, 2021. For most people, additional dose 1 is a booster. However, additional dose 1 may represent a supplement to the primary series for a people who is moderately or severely immunosuppressed. Bivalent booster administrations are not included in the additional dose 1 calculations. The percent with at least one dose many be over-estimated, and the percent fully vaccinated and with additional dose 1 may be under-estimated because of vaccine administration records for individuals that cannot be linked because of differences in how names or date of birth are reported. Race and ethnicity data may be self-reported or taken from an existing electronic health care record. Reported race and ethnicity information is used to create a single race/ethnicity variable. People with Hispanic ethnicity are classified as Hispanic regardless of reported race. People with a missing ethnicity are classified as non-Hispanic. People with more than one race are classified as multiple races. A vaccine coverage percentage cannot be calculated for people classified as NH Other race or NH Unknown race since there are not population size estimates for these groups. Data quality assurance activities sug
As of January 18, 2023, Portugal had the highest COVID-19 vaccination rate in Europe having administered 272.78 doses per 100 people in the country, while Malta had administered 258.49 doses per 100. The UK was the first country in Europe to approve the Pfizer/BioNTech vaccine for widespread use and began inoculations on December 8, 2020, and so far have administered 224.04 doses per 100. At the latest data, Belgium had carried out 253.89 doses of vaccines per 100 population. Russia became the first country in the world to authorize a vaccine - named Sputnik V - for use in the fight against COVID-19 in August 2020. As of August 4, 2022, Russia had administered 127.3 doses per 100 people in the country.
The seven-day rate of cases across Europe shows an ongoing perspective of which countries are worst affected by the virus relative to their population. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.